DALLAS, January 25, 2015
/PRNewswire/ --
MarketReportsOnline.com adds Global Biosimilar Market Trends
& Opportunities: 2015 Edition research report of 80 pages on
the biosimilars industry to the pharmaceuticals intelligence
collection of its research store.
The report titled "The Global Biosimilar Market: Trends &
Opportunities (2014-2018)" provides an in-depth analysis of the
growing Biosimilar Market with detailed analysis of market sizing
and growth, market share and economic impact of the industry. The
report also assesses the key opportunities in the market and
outlines the factors that are and will be driving the growth of the
industry. Growth of the overall Biosimilars industry has
also been forecasted for the period 2014-18, taking into
consideration the previous growth patterns, the growth drivers and
the current and future trends. Further, key players of the industry
like Sandoz, Teva, Hospira and Dr. Reddy's Lab are profiled.
Rising budgetary pressures to reduce healthcare expenditures,
patent expiries of blockbuster drugs, growing demand for
cost-effective alternatives, increasing aging population,
conductive government initiatives and rising incidences of various
diseases are significant factors that are responsible for the
growth of global biosimilar market (2013 to 2018). On the other
hand stringent regulatory environment in some countries, high
manufacturing complexities, costs, and presence of low priced
generic drugs and high-entry barriers are considered to hinder the
market growth. Emerging pharmaceutical market and less stringent
government regulatory frameworks in few countries can provides some
of the major opportunities for biosimilars market. In addition,
increased collaboration between manufacturing companies and
outsourcing of biosimilar products are key trends for biosimilars
market.
Purchase a copy of this research
report
at http://www.marketreportsonline.com/contacts/purchase.php?name=395635
.
The biosimilar products market is segmented into recombinant
non-glycosylated proteins, recombinant glycosylated proteins, and
recombinant peptides. Globally there are 280 biosimilars in
pipeline and their clinical trials are increasing at a rate of 20%
annually.
Product Coverage:
- Recombinant Glycosylated Biosimilars (EPO,mAb,Follitropin)
- Humira, Enbrel, Remicade, Herceptin
- Recombinant Non-Glycosylated Biosimilars
(Insulin,G-csf,Interferons,hGh)
This report analyzes the global biologics market, with
exhaustive discussion on demand of Biosimilars with increase in
patent expiry of innovator drugs. The key market challenges
recognized by the analysts and the major trends biosimilar market
are presented in the report.
Major points from Table of Contents are listed
below:
1. Executive Summary
2. Global Biosimilar Market
3. Global Biosimilar Market: Sizing and Growth
4. Biosimilar Market Analysis: By Geography
5. Biosimilar Market: Product Analysis
6. Market Dynamics of Biosimilar Market
7. Competitive Landscape: Global Biosimilar Market
8. Company profiles Global Biosimilar Market
List of Tables and Figures
Other Related Reports on Pharmaceuticals
Market:
US Pharmacy Benefit Management (PBM)
Industry Report: 2014 Edition
at http://www.marketreportsonline.com/395328.html .
Global Combined Hormonal Contraceptives (CHC) Market: Trends
and Opportunities (2014-19)
at http://www.marketreportsonline.com/394315.html.
About Us:
MarketReportsOnline.com comprises of an online library of
500,000 reports and in-depth market research studies of over 5000+
micro markets. We provide 24/7 online and offline support to our
customers. Get in touch with us for your needs of market research
reports.
Contact:
Ritesh Tiwari
TX, Dallas North - Dominion
Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
sales@marketreportsonline.com
SOURCE Market Reports Online